Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in United States


First Automated Insulin Delivery System in the World to Feature Dexcom’s Most Advanced CGM Technology

Tandem Diabetes Care (NASDAQ: TNDM), an insulin delivery and diabetes technology company, has launched an updated t:slim X2 insulin pump software with Dexcom G7 Continuous Glucose Monitoring (CGM) integration in the United States. Tandem’s  automated insulin delivery (AID) system* with Control-IQ technology is the only AID option to use Dexcom’s latest CGM technology.

Tandem will email instructions to all in-warranty t:slim X2 users in the United States to offer the option to add the new feature free of charge via remote software update. t:slim X2 pumps pre-loaded with the updated software are now shipping to new customers.

“With this launch we are offering more than 300,000 current t:slim X2 users the ability to integrate with Dexcom’s most advanced CGM technology, demonstrating our commitment to continued leadership in advancing AID systems,” said John Sheridan, president and chief executive officer of Tandem Diabetes Care.  “As we celebrate our 10-year partnership with Dexcom, we remain committed to sustaining our rapid pace of innovation to further our mission of helping improve the lives of people with diabetes.”

With the integration of Dexcom G7, t:slim X2 insulin pump users can now:

  • Spend more time in closed loop with little to no wait time between Dexcom G7 CGM sensor sessions.**
  • Use either a Dexcom G6 or Dexcom G7 CGM sensor, allowing even more choice in their diabetes management.

Dexcom G7, which is 60 percent smaller than its Dexcom G6 predecessor, offers a range of new features, including:

  •  Improved accuracy***
  • A 30-minute sensor warmup time, compared to 2 hours previously
  •  A 12-hour grace period to replace finished sensors for a more seamless transition between sessions and flexibility for when to change sensors

“The Dexcom G7 and t:slim X2 insulin pump integration is the culmination of years of partnership and a shared commitment to improve the lives of people with diabetes,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “We’re excited to bring our newest technology to Tandem users so they can experience the benefits of the smallest, most accurate, easy to use CGM connected to AID systems.”